Antivirals in immunocompromised patients
Public Health England (PHE) has issued updated guidance on prophylaxis of influenza in severely immunocompromised patients. It now recommends that zanamavir is used as the first line antiviral instead of oseltamivir. The guidance can be accessed via the PHE website.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20200636
Recommended from Pharmaceutical Press